"
Resistive Cerebral Blood Flow as a Potential Marker of Subclinical Brain Damage in Essential Hypertension"
written by Sergio González-García, Zenaida Hernández-Díaz, Luis Quevedo-Sotolongo, Marisol Peña-Sánchez, Yaima Pino-Peña, Rebeca Fernández-Carriera, Caridad Menéndez-Saínz, Alina González-Quevedo, Janis Eells,
published by
World Journal of Cardiovascular Diseases,
Vol.4 No.4, 2014
has been cited by the following article(s):
|
[1]
|
Asymptomatic cerebral small vessel disease in adults with low cardiovascular risk
BMJ Neurology Open,
2023
DOI:10.1136/bmjno-2022-000356
|
|
|
|
|
[2]
|
Stroke Biomarkers
Neuromethods,
2020
DOI:10.1007/978-1-4939-9682-7_8
|
|
|
|
|
[3]
|
Cerebral Small Vessel Disease Associated with Subclinical Vascular Damage Indicators in Asymptomatic Hypertensive Patients
Behavioral Sciences,
2019
DOI:10.3390/bs9090091
|
|
|
|
|
[4]
|
Serum neuron specific enolase could predict subclinical brain damage and the subsequent occurrence of brain related vascular events during follow up in essential hypertension
Journal of the Neurological Sciences,
2016
DOI:10.1016/j.jns.2016.02.052
|
|
|
|